Results 151 to 160 of about 1,229,815 (249)

Right Atrial Septal Electrode for Reducing the Atrial Defibrillation Threshold [PDF]

, 2001
Xiangsheng Zheng, Michael E. Benser, Gregory P. Walcott, Raymond E. Ideker   +3 more
openalex   +1 more source

Huge reduction of defibrillation thresholds four electrode defibrillators. 2014

, 2014
In the absence of a better solution, ventricular fibrillation is treated by applying one or several large electrical shocks to the patient. The question of how to lower the energy required for a successful shock is still a current issue in both fundamental research and clinical practice.
Simic, A. (Ana), Cantalapiedra, I.R. (Inma R.), Elorza-Barbajero, J. (Jorge), Bragard, J. (Jean)   +3 more
openaire   +1 more source

Fundamentals of System Design for Cardiac Pulsed Field Ablation: Optimization of Safety, Efficacy, and Usability

Pacing and Clinical Electrophysiology, Volume 49, Issue 1, Page 5-14, January 2026.
ABSTRACT The goal of a cardiac pulsed field ablation (PFA) system is to provide safe, effective, and usable therapy for the treatment of cardiac arrhythmias. Achieving this goal is a complex exercise in system design, requiring optimization of catheter, waveform, and dosing. This optimization is often iterative, as myriad design factors are balanced to
Brendan Koop
wiley   +1 more source

Defibrillation threshold decrease with the supradiaphragmatic extracardiac implantable cardioverter-defibrillator implantation technique [PDF]

, 2010
Antonio Berruezo, Hrvojka Marija Zeljko, J. Bartrons, Julio Mayol, Fredy Prada, Josép Brugada   +5 more
openalex   +1 more source

Pulsed Field Ablation in Patients With Cardiac Implantable Electric Devices: Vigilance Is Warranted

Pacing and Clinical Electrophysiology, Volume 49, Issue 1, Page 58-66, January 2026.
ABSTRACT Pulsed field ablation (PFA) for the treatment of atrial fibrillation offers potential safety benefits compared to thermal ablation modalities. However, the high voltage electric pulses required to irreversibly electroporate myocardial cells present a unique clinical challenge in regard to patients with cardiac implantable electronic devices ...
Brendan E. Koop, Elizabeth M. Albrecht, Emily Lecy, James Kippola   +3 more
wiley   +1 more source

Arrhythmic triad in an implantable cardioverter‐defibrillator recipient with severe hypokalemia

Journal of Arrhythmia, 2022
Giovanni Domenico Ciriello, Gabriella Gaudieri, Flavio Cesaro, Raffaele Merenda, Vincenzo Russo   +4 more
doaj   +1 more source

Sedation Strategies for Defibrillation Threshold Testing: Safety Outcomes with Anesthesiologist Compared to Proceduralist-Directed Sedation. An Analysis from the Shockless Implant Evaluation (SIMPLE) Study

, 2018
Kenneth Quadros
openalex   +1 more source

Low‐Dose Mavacamten Initiation in Obstructive Hypertrophic Cardiomyopathy: A Real‐World Study in China

Cardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Aims To evaluate the real‐world efficacy and safety of low‐dose (2.5 mg) mavacamten initiation in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Methods and Results This single‐center observational study (Zhongshan Hospital, China; Oct 2024–Apr 2025) enrolled 72 symptomatic oHCM patients (NYHA II/III, LVEF ≥ 55 ...
Wenlong Yang, Hui Shi, Rebecca Suchi Chang, Yin Zhang, A. Jixiang, Chunyu Wu, Juying Qian, Junbo Ge, Shuning Zhang, Baohui Xu   +9 more
wiley   +1 more source

The Usefulness of Echocardiography for Predicting High Defibrillation Threshold (DFT)

, 2011
Mayuko Yagawa, Kanki Inoue, Mitsumi Yamashita, Kohei Tanizaki, Jun Umemura   +4 more
openalex   +1 more source

Epicardial Conductors Can Lower the Defibrillation Threshold in Rabbit Hearts

, 2020
J.A. Sims, S.B. Knisley
openalex   +1 more source